stockrowMedpace Holdings, Inc.
MEDP Healthcare Diagnostics & Research
Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.
- Revenue
- +8.50%
- EPS
- +24.6%
- Free cash flow
- −16.6%
Quarter to September 2026, against a year earlier
Follow MEDP
Alert me
Medpace Holdings, Inc. (MEDP) Shares outstanding
Medpace Holdings, Inc.'s shares outstanding at the end of fiscal 2025 was $29.5M, down 7.77% from $32.0M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $28.4M. Over the past ten years it has ranged from $29.5M (fiscal 2025) to $39.8M (fiscal 2017) — the current reading is the lowest in ten years. Medpace Holdings, Inc. ranks 35th of 49 Diagnostics & Research companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $29.5M | (7.77%) |
| FY2024 | $32.0M | 0.54% |
| FY2023 | $31.8M | (5.43%) |
| FY2022 | $33.7M | (10.68%) |
| FY2021 | $37.7M | (0.03%) |
| FY2020 | $37.7M | 0.35% |
| FY2019 | $37.6M | 1.80% |
| FY2018 | $36.9M | (7.35%) |
| FY2017 | $39.8M | 9.66% |
| FY2016 | $36.3M | 15.90% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $28.4M | (0.64%) |
| Jun 2026 | $28.6M | (1.41%) |
| Mar 2026 | $29.0M | (1.91%) |
| Dec 2025 | $29.5M | 2.46% |
| 40 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| QGEN QIAGEN N.V. compare | $207.8M |
| ILMN Illumina, Inc. compare | $154.0M |
| GH Guardant Health, Inc. compare | $134.4M |
| DGX Quest Diagnostics Incorporated compare | $112.0M |
| RVTY Revvity Inc. compare | $111.8M |
| LH Labcorp Holdings Inc. compare | $81.6M |
| ICLR ICON PLC compare | $77.4M |
| CRL Charles River Laboratories International, Inc. compare | $48.6M |
| MEDP Medpace Holdings, Inc. | $28.4M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on MEDP
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement